DCM
ABBV icon

Delpha Capital Management’s AbbVie ABBV Stock Holding History

Delpha Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,357
Closed -$131K – 141
2017
Q4 		$131K Buy
+1,357
New +$128K 0.14% 103

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Delpha Capital Management's ABBV Position: Q1 2018 in Review

Delpha Capital Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 1,357 shares — an estimated $131K sold.

Delpha Capital Management first reported a position in ABBV in Q4 2017 and held it in 1 quarter. The position peaked at $131K in Q4 2017. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Delpha Capital Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 1,357 AbbVie shares in Q1 2018, an estimated $131K.
  • Delpha Capital Management first reported a position in AbbVie in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's AbbVie position peaked at $131K in Q4 2017.
  • 2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.